MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » CEO Shortall, COO Mojdeh out as Unilife retools | Personnel Moves

CEO Shortall, COO Mojdeh out as Unilife retools | Personnel Moves

By

MassDevice.com Personnel Moves

Unilife (NSDQ:UNIS) said today that chairman & CEO Alan Shortall and president & COO Ramin Mojdeh are out, effective immediately, as it reorganizes to focus on its revenue-generating programs with existing customers.

Unilife, which finally sealed the deal with Amgen last month for an injectable drug delivery system, said it will create a pair of new business units: Wearable & auto-injectors and pre-filled syringes.

General counsel, secretary & SVP John Ryan will serve as interim CEO while York, Pa.-based Unilife looks for a replacement for Shortall.

“I am proud of the many achievements of our team, which strongly position Unilife for global success,” Shortall said in prepared remarks. “Unilife has the focus, capabilities and talent to successfully execute this new stage of growth, where the pursuit of efficient operations and profitability will be strategic priorities. I am grateful to have been able to see my vision through to this day, and I remain available to Unilife as a consultant as the company takes important steps to reach the next level.”

Unilife said it also named vice chair and lead independent director Mary Kate Wold as chairwoman; Wold is slated to head an executive leadership team comprised of Ryan; CFO & SVP David Hastings; wearable injector & auto-injector general manager & SVP Ian Hanson; and Michael Ratigan, chief commercial officer & SVP.

“We are grateful to Alan and Ramin for their extraordinary vision and passion,” Wold said. “As founder and long-term CEO of Unilife, Alan has been a critical part of Unilife’s achievements to-date and the Company has benefited from his perseverance, enthusiasm and leadership. Ramin’s leadership in developing industry-leading technology and bringing together a highly-talented and innovative team has positioned Unilife for future success.

“John, Dave, Ian and Mike have been strong and effective leaders for Unilife, with excellent industry and business experience. They are supported by an outstanding senior management team with deep industry experience and a proven track record of success at Unilife,” Wold added. “With their collaborative leadership, we anticipate that this time of transition will be seamless for our customers, employees and investors.”

 GE Healthcare names Koontz as IT chief
GE Healthcare (NYSE:GE) said it named Charles Koontz, former EVP of federal civilian agencies at Computer Sciences Corp., as president & CEO of GE Healthcare IT and chief digital officer of GE Healthcare itself.
Read more

 AxoGen lures ex-Stryker exec Leach for marketing veep
AxoGen said it lured former Stryker (NYSE:SYK) global knee marketing VP Kevin Leach to be its new marketing VP, effective today.
Read more

 RIP former J&J CEO Larsen
Former Johnson & Johnson (NYSE:JNJ) chairman & CEO Ralph Larsen, who led the healthcare conglomerate from 1989 to 2002, died of cardiac arrest March 9 at his home in Naples, Fla.
Read more

 HeartWare names ex-MDTer Cornell to board
HeartWare International (NSDQ:HTWR) said it named former Medtronic (NYSE:MDT) corporate development vice president Chadwick Cornell to its board of directors.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Owens & Minor and Allina Health partner on supply chain resiliency
    Owens & Minor (NYSE: OMI) and Minneapolis-based Allina Health are partnering on what they call a “unique integrated service model for supply chain resiliency.” An Owens & Minor distribution center that has been in operation for more than 25 years in Moundsview, Minnesota will serve as the integrated service center powering the model, the companies… […]
  • Chronic pain researchers say sound and electrical stimulation has treatment potential
    University of Minnesota researchers are using sound and electrical stimulation to treat chronic pain and other sensory disorders without pharmaceutical drugs. The combination of sound and stimulation activates the brain’s somatosensory cortex, according to a study on guinea pigs published in the Journal of Neural Engineering. Also known as the tactile cortex, the somatosensory cortex is… […]
  • What Laura Mauri learned from a ‘firestorm’ in her first months at Medtronic
    Dr. Laura Mauri faced a monumental moment with former Medtronic CEO Omar Ishrak shortly after she joined the company as VP of global clinical research and analytics. It was late 2018, and Mauri — who’s now an SVP and the chief scientific, medical and regulatory officer at Medtronic (NYSE: MDT) — was in a meeting… […]
  • Senators seek post-market FDA study of pulse oximeters and skin color
    Democratic U.S. senators are prodding the FDA to launch a post-market study of pulse oximeters due to unreliable performance for patients with dark skin. Pulse oximeters estimate blood oxygen levels (SpO2) and pulse rates in patients using infrared light — usually on a fingertip — at home or in clinical settings. Blood oxygenation is one… […]
  • TE Connectivity opens global medical device prototyping center in Ireland
    TE Connectivity (NYSE:TEL) today announced it opened its global Propelus Prototype Center for medical devices in Galway, Ireland. The $5 million rapid prototyping center was built into its existing manufacturing site in Galway and directly connects TE engineers with customers to reduce development time and increase speed to market for lifesaving and life-improving medical devices. Propelus… […]
  • Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye
    Minnetronix Medical has launched MindsEye, making it the first medical device that the contract developer and manufacturer has conceived and commercialized. St. Paul-based Minnetronix Medical’s MindsEye is the first expandable brain access port on the market. The FDA cleared the device under the 510(k) pathway in August 2020. The minimally invasive device gives neurosurgeons deep… […]
  • What’s next for Jennifer Fried after leaving Explorer Surgical?
    Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October. Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter. “It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown… […]
  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]